Anti-Human CD47 [B6H12] In Vivo Antibody - Low Endotoxin
- SKU:
- IVMB0313
- Product Type:
- In Vivo Monoclonal Antibody
- Clone:
- B6H12
- Protein:
- CD47
- Isotype:
- IgG1 k
- Reactivity:
- Human
- Synonyms:
- IAP
- Synonyms:
- OA3
- Synonyms:
- neutrophilin
- Synonyms:
- gp42
- Synonyms:
- MEM-133
- Synonyms:
- CDw149
- Synonyms:
- ITPG
- Research Area:
- Immunology
- Endotoxin Level:
- Low Endotoxin
- Host Species:
- Mouse
- Applications:
- FA
- Applications:
- FC
- Applications:
- In Vivo
- Applications:
- N
Description
Product Name: | Anti-Human CD47 (Clone B6H12) In Vivo Antibody - Low Endotoxin |
Product Code: | IVMB0313 |
Size: | 1 mg, 5 mg, 25 mg, 50 mg, 100 mg |
Clone: | B6H12 |
Protein: | CD47 |
Product Type: | Monoclonal Antibody |
Synonyms: | IAP, OA3, neutrophilin, gp42, MEM-133, CDw149, ITPG |
Isotype: | IgG1 k |
Reactivity: | Human |
Applications: | FA, FC, In Vivo, N |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Product Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Applications: | FA, FC, In Vivo, N |
Reactivity: | Human |
Host Species: | Mouse |
Specificity: | Clone B6H12 recognizes an epitope on human CD47. |
Antigen Distribution: | CD47 is expressed on leukocytes, platelets, erythrocytes, epithelial cells, endothelial cells, fibroblasts, and is overexpressed in ovarian cancer, as well as many different tumor cells. |
Immunogen: | Purified Recombinant Human CD47 (>98%) |
Concentration: | 1.0 - 5.0 mg/ml |
Endotoxin Level: | < 1.0 EU/mg as determined by the LAL method |
Formulation: | This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration. |
Purity: | ≥95% monomer by analytical SEC ⋅ >95% by SDS Page |
Preparation: | Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates. |
Storage and Handling: | This Low Endotoxin Functional Formulation conjugate is stable when stored at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles. |